Bhuvnesh K Sharma, PhD is a Senior Director R&D (Translational Oncology) at ScyTeK Laboratories Inc., Logan UT, USA. He also holds appointment as Consultant, Celprogen Inc. Torrance, CA. He did his Post-Doctoral Trainings in Molecular Oncology/ Immuno-Virology at St. Mary’s Hospital Medical School, London, UK and Johns Hopkins University Medical Institutions, Baltimore, MD, USA.

Dr. Sharma has previously served as Adjunct Associate Professor, Georgetown Univ. School of Medicine Washington DC; Senior Scientist, Weinberg Cancer Institute MedStar Health Franklin Square Medical Center, Baltimore, MD; Deputy Director of Institute of Preventive Oncology, N. Delhi, India; Visiting Scholar, Johns Hopkins University, Baltimore, MD; Visiting Scientist, Univ. of Maryland School of Medicine, Baltimore, MD. Dr. Sharma is the recipient of awards & other distinguished recognitions for his discoveries on predictive cancer biomarkers. He has published numerous articles on cancer biomarkers and conducted research reviews on Emerging Cancer Vaccines and Intralesional tumor Immunotherapy. He is a noted expert in Melanoma Stem Cell research and Newer Optimism for Targeted Cancer Therapeutics. Dr. Sharma is also serving as an editorial board member of prestigious journals in Biomedicine/ Stem Cell Research/ Oncology.

Primary Affiliation: SycTek Lab.Inc - Utah , United States

Specialties: Translational Cancer Research

Research Interests: Preclinical Cancer Research, Cancer Stem Cell Research, Genomic Tumor Pathology,, Diagnostic Immunohistochemistry, Predictive Cancer Tissue Biomarkers, Tumor Immuno-Virology, Companion Cancer Diagnostics, Exploratory Adjuvant Tumor Immunotherapy.


CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM).
J Invest Dermatol 2005 Jun;124(6):1215-24
Department of Pharmacology and Experimental Therapeutics, The University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.